CD8A and neoplasm: Capacity to build multicytokine CD4+ and CD8+ T cell response against epitopes in TERT1, TERT6, and TERT8 (specifically, TERT6 and TERT8, Supplementary Table S4) discriminated mice that were able to restrict tumor growth.